CLINICAL_TRIALS
withdrawal
· 2017-01-12
Clinical Trial Update: A Study to Evaluate the Effects of the Neuroflo Device in People Who Have Had a Stroke [Phase 1]
Summary
A Phase 1 study evaluating the Neuroflo device for acute stroke has been withdrawn.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: University of California, Los Angeles | Conditions: Acute Stroke | Phase 1 | Status: WITHDRAWN